of LpPLA2 have been identified in fermentations of Pseudomonasfluorescens. The two structurally isomeric series differ in the geometry of closure of the bicyclic carbamate and comprise a range of compounds varying only in length of their lipophilic sidechain. The most abundant species were extracted from the cells and purified by silica and C18 chromatography. Membersof the more stable class were shown to be potent and selective competitive inhibitors of LpPLA2.
Pseudomonasfluorescens. The two structurally isomeric series differ in the geometry of closure of the bicyclic carbamate and comprise a range of compounds varying only in length of their lipophilic sidechain. The most abundant species were extracted from the cells and purified by silica and C18 chromatography. Membersof the more stable class were shown to be potent and selective competitive inhibitors of LpPLA2.
Lipoprotein-associated phospholipase A2 (LpPLA2) is responsible for the conversion of phosphatidylcholine to lysophosphatidylcholine and oxidised free fatty acids during the conversion of low density lipoprotein to its oxidised form1^Both products are potent chemoattractants for circulating monocytes.2) Lysophosphatidylcholine results in rnacrophage proliferation3} and the endolithial dysfunction4'5) observed in patients with atherosclerosis.
Inhibition of LpPLA2would be expected to stop plaque build-up and provide an attractive strategy in the treatment of atherosclerosis and related disorders. In this article we describe the fermentation of the producing strain and the isolation and biological properties of the most abundant actives isolated from cultures of DSM 1 1 579. The structural elucidation7) and biotransformation8) of these compounds is described in the accompanying articles.
Materials and Methods

Producing Strain
The bacterium DSM11579 was isolated from a soil sample from Texas (USA Plates were visualised by UV(254nm) and staining with 10% ammoniummolybdate in 2 m H2SO4followed by heat.
The active components ran closely together at Rf 0.22-0.25.
Inoculum Preparation
The contents of a cryovial of Pseudomonas fluorescens strain DSM11579 was grown on Oxoid Blood Agar Base in Petri dishes at 30°C. After one day, a loopful of well grown culture was used to inoculate 30ml of Oxoid Tryptone Soya Broth in a 250ml plain shake flask. The flasks were incubated at 28°C, 250rpm (5 cm throw) for 24 hours then the culture was mixed 1 : 1 with cryopreservative (20% glycerol, 10% lactose) and stored in cryovials at -80°C.
Small Scale Fermentation
250ml shake flasks containing 30ml of YMmedium (Bacto Peptone 0.5%, Difco Yeast Extract 0.3%, malt extract 0.3%, glucose 1%) were inoculated (4-5%) with cell suspension prepared as above, then incubated at 28°C, 250rpm (5 cm throw) for 7 days.
A 500ml shake flask containing 100ml L-broth seed medium (Difco Yeast Extract 0.5%, Difco Tryptone 1%, NaCl 1%, pH 7.4) was inoculated with 0.5ml from a cryovial and incubated at 28°C, 240rpm (5 cm throw) for 24 hours. This culture was used to inoculate (4-5% v/v) five, 2 liters plain shake flasks containing 400ml L-broth seed medium which were incubated for 24 hours at 28°C, 240 rpm (5 cm throw).
40 liters of F12 production medium (glucose 20%, Arkasoy 1%, spray dried corn steep liquor 0.125%,
NaHPO4 0.325%, pH 7.0) together with 0.1% v/v SAG471 antifoam was sterilized in a 75 liters stainless steel fermenter at 121°C for 45 minutes using in situ steam sterilisation.
After cooling to 26°C, the fermenter was inoculated with 2 liters of a 24 hours seed culture.
Fermenters were incubated at 26°C, 0.5 bar overpressure with an air flow of 0.75 vessel volumes per minute and a rotor speed of 400rpm. After 78 hours the culture was adjusted to pH 4.0-4.5 with orf/zo-phosphoric acid (9 m Within each class the various species differed in mass by 28 or 26 amu, suggesting that they incorporated varying lengths of fatty-acids ( series ' a' particularly so.
A 40 liter fermentation of strain DSM1 1579 was carried out in a 75 liter vessel to provide material for isolation of the major actives. After a 20 hour lag phase the titer of 3b steadily increased and was accompanied by a drop in pH (Fig. 2) . Packed cell volume remained essentially constant -291073) due to the highly particulate composition of the media and the dissolution of the CaCO3as pH dropped. Following a plateau in accretion of 3b at 78 hours, the culture was pasteurised by heating to 75°C, then the broth was cooled and centrifuged to recover the cells and media solids. The resulting cell slurry was diluted with methanol to 70%v/v, stirred for 1 hour, then re-centrifuged to generate a clear ambercoloured extract.
Isolation and Purification
The major active components (l~6b, 3a, 4a) produced by fermentation of Pseudomonas fluorescens DSM1 1579 were isolated from the methanolic cell extract by chromatography as shown (Fig. 3) .
Spectroscopic studies on the purified SB-253514 (3b) and SB-315021 (3a) indicated that series 'b' incorporated a novel 5 : 5 bicyclic carbamate moiety, whilst series 'a' incorporated a 7:5 carbamate moiety as found in cyclocarbamide a/b10). Structures are indicated in Table 2 . Full details of the structural elucidation of these compoundsis presented in the accompanying paper.7)
Biological Properties
The isolated compounds were assayed against recombinant LpPLA2. Measurements were made both with Table 2 . Inhibition ofLpPLA2 by isolated metabolites. and without a 10 minutes pre-incubation as the inactivatiori appeared time dependent (Table 2 ). The 5 : 5 (series ' b' ) compounds were competitive vs. DNPG and IC50 varied with the length of the side chain. LCMS experiments indicated the formation of a 1 : 1 covalent complex between LpPLA2and 3b and further kinetic analysis indicated very slow reactivation (T1/2>24 hours). Due to the instability of the 7 : 5 nucleus only the most abundant memberof series ' a' (3a) was tested and this gave poor inhibition, presumably due its instability under the assay conditions. Potent LpPLA2inhibition was similarly demonstrated by 3b using isolated rabbit and human plasma. Good inhibitory activity was observed when 3b was dosed intravenously to Watanabe heritable hyperlipidaemic rabbit, however, when dosed orally, no inhibition was observed. In order to determine its selectivity 3b was screened against porcine elastase, trypsin, chymotrypsin, thermolysin, fungal aspartic protease, bacterial type IX metalloprotease and the herpes protease enzymes (CMV, VZV, HSV-2). No inhibition of these enzymes was observed, however, moderate inhibition of PAF acetylhydrolase II did occur (IC50 485nm, 10 minute pre-incubation).
When tested against a panel CYP450isozymes, 3b showed no inhibition.
Discussion
The metabolites produced by Pseudomonasfluorescens strain DSM1 1579 are present as two series of structurally isomeric 'twins', sharing the same fatty-acid derived backbones but differing in the geometry of closure of the bicyclic carbamate. Under the fermentation conditions used for this work, the more stable 5 : 5 series was predominant. The structural similarities between the series suggests that the two classes share a series of commonprecursors, possibly an acyclic /3-ketoimide. Of the species characterised so far, a range of fatty acids from 12 to 18 carbons in length are utilized but, a numberof other more lipophilic species are present in these fermentations. The cross screening results, and LCMS observation of a covalent adduct between LpPLA2and 3b indicate that in addition to being potent inhibitors of LpPLA2, these compoundsare selective and irreversible acylators. Whilst 3b was not orally active, enzymatic deglycosylation8) of this compoundresulted in an orally active metabolite. Lysophosphatidylcholine: a chemotactic factor for humanmonocytes and its potential role in atherogenesis.
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